Abstract
Backround: Over the last decade a synchronous resection of liver metastases and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) have emerged. It is still more widely accepted in cases of small peripheral hepatic lesions. We report short- and long-term outcome of patients undergoing CRS+HIPEC combined with liver resections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.